Farallon Capital Management LLC Sells 1,319,000 Shares of GE HealthCare Technologies Inc. $GEHC

Farallon Capital Management LLC lowered its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 99.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,000 shares of the company’s stock after selling 1,319,000 shares during the quarter. Farallon Capital Management LLC’s holdings in GE HealthCare Technologies were worth $225,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of GEHC. Godsey & Gibb Inc. acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $26,000. E Fund Management Hong Kong Co. Ltd. lifted its stake in GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares during the last quarter. Oakworth Capital Inc. lifted its stake in GE HealthCare Technologies by 1,876.2% in the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after purchasing an additional 394 shares during the last quarter. Piscataqua Savings Bank grew its holdings in GE HealthCare Technologies by 173.4% during the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after purchasing an additional 300 shares during the period. Finally, Salomon & Ludwin LLC grew its holdings in GE HealthCare Technologies by 326.5% during the third quarter. Salomon & Ludwin LLC now owns 482 shares of the company’s stock worth $37,000 after purchasing an additional 369 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.6%

Shares of NASDAQ:GEHC opened at $70.77 on Monday. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $89.77. The stock has a market cap of $32.25 billion, a PE ratio of 15.52, a P/E/G ratio of 1.56 and a beta of 1.03. The business has a 50 day moving average of $80.78 and a 200-day moving average of $78.54. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is currently 3.07%.

Analyst Ratings Changes

GEHC has been the topic of several research analyst reports. Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Jefferies Financial Group lifted their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Barclays boosted their target price on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a report on Friday, February 6th. Wells Fargo & Company increased their price target on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Finally, Morgan Stanley raised their price target on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Wednesday, February 4th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $92.17.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.